SEOUL, April 5- Samsung Electronics is spending more on marketing than R&D for the first time in at least three years, prompting some pundits to warn that the IT giant is sacrificing innovation at a time when the market is teeming with ever smarter gadgets.
April 4- Here is a list of economic questions that have something in common. In a recession, should governments reduce budget deficits or increase them? Do zero percent interest rates stimulate economic recovery or suppress it?
*Under new CEO, Sarepta focused on Duchenne muscular dystrophy drug. *Analysts expect company to relay FDA feedback in April. April 2- After three decades without bringing a drug to market, Sarepta Therapeutics Inc stands on the verge of a breakthrough with its treatment for a crippling genetic disorder that affects one in every 3,500 newborn boys.
LONDON/ MUMBAI, April 2- Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world's eighth largest market for medicines by 2016..
LONDON, April 2- Britain launched its new system of financial supervision on Tuesday, hoping that two new regulators will succeed where a single one failed in preventing banking crises and protecting consumers from getting fleeced.
March 27- U.S. Food and Drug Administration:. *FDA says approved Biogen idec's tecfidera. capsules to treat adults with relapsing forms of Multiple Sclerosis.
DETROIT, March 27- General Motors Co is laying the groundwork to achieve 10 percent profit margins by mid-decade by launching new models and taking better advantage of its global scale, North American Chief Financial Officer Chuck Stevens said.
NEW YORK, March 27- Swedish automaker Volvo Car will introduce its first all-new vehicle as a unit of China's Zhejiang Geely Holding Group Co Ltd in late 2014, Volvo Chief Executive Hakan Samuelsson said on Wednesday.